Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

Monitoring circulating tumor cells in vivo by a confocal microscopy system

Algorithm to Identify Circulating Tumor Cell Clusters Using in Vivo Flow Cytometer

Advances of In Vivo Flow Cytometry on Cancer Studies

Real Time Monitoring of Daily Variation of Circulating Tumor Cells by in Vivo Flow Cytometry (conference Presentation)

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Digital Circulating Tumor Cells Quantification

Progress in Detection of CirculatingTumor Cell byin vivo Photoacoustic Flow Cytometry

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Detection of circulating tumor cells: opportunities and challenges

Advances in isolation and detection of circulating tumor cells based on microfluidics

Detection of Cells by Flow Cytometry: Counting, Imaging, and Cell Classification

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Nano/Micro Fluidic Systems for Circulating Tumor Cells (ctcs) Rapid Detection and Diagnosis

Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Recent advances in fluorescence-based in vivo flow cytometry